· Original article
Cleveland-Cliffs earnings preview: Q3 due October 19
Cleveland-Cliffs earnings are due October 19, 2026. Analysts expect positive EPS and higher revenue as investors assess profitability and cash flow.
FINANCEVELIX / News
Equities & companies · Page 61
Equities & companies
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Read the original source and publication date in each article.
Equities & companies
RSSResults: 1,826 · Page 61 / 153
· Original article
USAC distribution holds at $0.525, payable November 6
The USAC distribution remains $0.525 per unit, payable November 6, 2026. Earlier debt pricing specified repayment of credit-agreement borrowings.
· Original article
Travelers results show Q3 profit growth and $1.5bn buybacks
Travelers results showed higher third-quarter profit, record investment income and $1.5 billion in buybacks, while catastrophe losses increased.
· Original article
AI shopping exposes contrasting Amazon and Walmart strategies
AI shopping highlights contrasting retailer strategies, with Walmart planning ChatGPT checkout and Amazon resisting Perplexity’s shopping agent.
· Original article
Lemon Tree Hotels signs Omaxe MoU for about 4,000 rooms
Lemon Tree Hotels' subsidiary signs an MoU with Omaxe for about 4,000 rooms in India, taking its development pipeline to nearly 16,000 rooms.
· Original article
NuRAN expansion targets 1,650 sites as CEO plans Africa talks
NuRAN expansion plans target 1,650 operating sites by mid-2028, subject to financing, as its CEO prepares for November telecom meetings in Cape Town.
· Original article
US stocks mixed as AI concerns hit chips and banks gain
US stocks diverged on October 16, 2026, as chipmakers and AI infrastructure shares fell while bank gains helped support the Dow.
· Original article
Propanc PRP research targets pancreatic cancer resistance
Propanc PRP research shows preclinical effects in chemotherapy-resistant pancreatic cancer cells, with a first-in-human study planned for Q1 2027.
· Original article
ATNM-400 data support wider solid-tumor research at Actinium
Actinium announced preclinical ATNM-400 data across lung, colorectal and ovarian cancer models ahead of EANM 2026 presentations in Vienna.
· Original article
Foundayo recommendation advances Lilly’s EU diabetes bid
The Foundayo recommendation disclosed on October 16 advances Eli Lilly’s adult type 2 diabetes application, but is not a final marketing authorization.
· Original article
Emergent CFO Richard Lindahl to retire; shares fall premarket
Emergent CFO Richard Lindahl will retire at year-end 2026. Treasurer Frank Vargo will take over on an interim basis, with advisory support through March.
· Original article
Lufax CFO appointment brings Jia Liu to finance leadership
Lufax CFO Jia Liu took up the role on October 16, 2026, bringing experience in banking, fintech finance and capital raising at CITIC aiBank and Yiren Digital.
Charts and market data by TradingView. Availability and delays vary by exchange.